- OPTN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
OptiNose (OPTN) 8-K6 Dec 23Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCEFinancial data
Company Profile